Edition:
India

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

3.10USD
22 Jun 2018
Change (% chg)

$0.17 (+5.80%)
Prev Close
$2.93
Open
$2.92
Day's High
$3.18
Day's Low
$2.87
Volume
2,101,289
Avg. Vol
345,434
52-wk High
$8.61
52-wk Low
$1.41

Chart for

About

Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. It has developed the Disease Relevant... (more)

Overall

Beta: --
Market Cap(Mil.): $55.48
Shares Outstanding(Mil.): 25.10
Dividend: --
Yield (%): --

Financials

BRIEF-Proteostasis Therapeutics Says CFO Helen Boudreau Provided Notice Of Resignation

* PROTEOSTASIS THERAPEUTICS SAYS ON MAY 2, CFO AND TREASURER, HELEN BOUDREAU, PROVIDED NOTICE OF RESIGNATION TO PURSUE ANOTHER PROFESSIONAL OPPORTUNITY

07 May 2018

BRIEF-Proteostasis Therapeutics Files For Mixed Shelf Of Up To $100 Mln

* PROTEOSTASIS THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING Source text: [https://bit.ly/2H14NPj] Further company coverage:

07 Apr 2018

BRIEF-Proteostasis Receives FDA Fast Track Designation For Triple Combination Program In Patients With Cystic Fibrosis

* PROTEOSTASIS THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR TRIPLE COMBINATION PROGRAM IN PATIENTS WITH CYSTIC FIBROSIS

04 Apr 2018

BRIEF-Proteostasis Announces Proposed Public Offering Of Common Stock

* PROTEOSTASIS THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

20 Mar 2018

BRIEF-Proteostasis Therapeutics Expects Cash, Cash Equivalents,Short-Term Investments To Be Enough To Fund Its Operating Expenses

* PROTEOSTASIS THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

15 Mar 2018

BRIEF-Proteostasis Therapeutics Sees Cash, Cash Equivalents Balance As Of Dec 31, Sufficient To Fund Operations Into Early 2019​

* PROTEOSTASIS THERAPEUTICS INC - CO ESTIMATES CASH, CASH EQUIVALENTS BALANCE AS OF DEC 31, 2017, SUFFICIENT TO FUND OPERATIONS INTO EARLY 2019​ Source text: (http://bit.ly/2FWFOfk) Further company coverage:

14 Mar 2018

Earnings vs. Estimates